| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.42B | +19.8% | +6.1% |
| Gross Profit | $614.6M | +19.5% | +7.0% |
| R&D Expense | $78.5M | +3.1% | +0.6% |
| SG&A Expense | $41.9M | +0.3% | -0.5% |
| Operating Income | $286.0M | +49.5% | +21.9% |
| Pre-tax Income | $299.1M | +47.3% | +22.0% |
| Income Tax | $48.1M | +48.5% | +6.7% |
| Net Income | $251.0M | +47.1% | +25.4% |
| EPS (Basic) | $1.71 | +47.4% | +28.6% |
| EPS (Diluted) | $1.69 | +47.0% | +28.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.82B | +32.1% | +21.0% |
| Accounts Receivable | $683.1M | -3.0% | +5.4% |
| Inventory | $449.5M | -13.2% | -7.0% |
| Current Assets | $3.12B | +13.4% | +12.4% |
| Total Assets | $4.10B | +10.5% | +9.8% |
| Current Liabilities | $1.41B |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $834.4M | — | — |
| Capital Expenditures | $47.7M | — | — |
| Investing Cash Flow | -$48.8M | — | — |
| Financing Cash Flow | -$483.7M | — | — |
| Free Cash Flow | $786.7M | — | — |
| +8.8% |
| Total Liabilities | $1.76B | +8.4% | +8.1% |
| Stockholders' Equity | $2.34B | +12.1% | +11.1% |